Review
References
|
Aslebagh R, Wormwood KL, Channaveerappa D, Wetie AGN, Woods AG, Darie CC (2019). Identification of Posttranslational Modifications (PTMs) of Proteins by Mass Spectrometry. In: Woods A, Darie C (eds) Advancements of Mass Spectrometry in Biomedical Research. Advances in Experimental Medicine and Biology, vol 1140. Springer, Cham. |
|
|
Atanasov AG, Zotchev SB, Dirsch VM, Orhan IE, Banach M, Rollinger JM, Barreca D, Weckwerth W, Bauer R, Bayer EA, Majeed M, Bishayee A, Bochkov V, Bonn GK, Braidy N, Bucar F, Cifuentes A, D'Onofrio G, Bodkin M, Diederich M, Dinkova-Kostova AT, Efferth T, El Bairi K, Arkells N, Fan T-P, Fiebich BL, Freissmuth M, Georgiev MI, Gibbons S, Godfrey KM, Gruber CW, Heer J, Huber LA, Ibanez E, Kijjoa A, Kiss AK, Lu A, Macias FA, Miller MJS, Mocan A, Müller R, Nicoletti F, Perry G, Pittalà V, Rastrelli L, Ristow M, Russo GL, Silva AS, Schuster D, Sheridan H, Skalicka-Wo?niak K, Skaltsounis L, Sobarzo-Sánchez E, Bredt DS, Stuppner H, Sureda A, Tzvetkov NT, Vacca RA, Aggarwal BB, Battino M, Giampieri F, Wink M, Wolfender J-L, Xiao J, Yeung AWK, Lizard G, Popp MA, Heinrich M, Berindan-Neagoe I, Stadler M, Daglia M, Verpoorte R (2021). Natural products in drug discovery: advances and opportunities. Nature Reviews Drug Discovery 20(3):200-216. |
|
|
Atri V, Causon T, Hernandez-alba O, Mutabazi A, Veuthey J, Cianférani S, Guillarme D, Atri V, Causon T, Hernandez-alba O, Mutabazi A, Veuthey J (2020). Adding a new separation dimension to MS and LC-MS?: What is the utility of ion mobility spectrometry?? To cite this version: HAL Id?: hal-01702282. |
|
|
Bano I, Baloch AR, Arbab S, Sajjad H, Talpur MSH, Khalid A (2021). A Novel Concept for Nano-Selenium Supplementation to Fight against COVID-19. International Journal of Clinical and Experimental Medicine Research 5(3):264-268. |
|
|
Bano I, Sajjad H, Sajjad M, Talpur H, Leghari A, Mirbahar KH (2016). Role of selenium on oxidative stress and male reproductive system. Pakistan Journal of Biochemistry and Molecular Biology 49(4):75-79. |
|
|
Bano I, Sciences A (2018). Research progress on the role of melatonin and its receptors in animal reproduction?: A comprehensive review. October 2017. |
|
|
Chahrour AO, Malone J, Collins M, Salmon V, Greenan C, Bombardier A, Ma Z, Dunwoody N (2017). Development and validation of an ICP-MS method for the determination of elemental impurities in TP-6076 active pharmaceutical ingredient (API) according to USP ?232?/?233?. Journal of Pharmaceutical and Biomedical Analysis. |
|
|
DiMasi JA, Hansen RW, Grabowski HG (2003). The price of innovation: New estimates of drug development costs. Journal of Health Economics 22(2):151-185. |
|
|
Gillette MA, Carr SA (2013). Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry. Nature Methods 10(1):28-34. |
|
|
Ito K (2007). Impact of post-translational modifications of proteins on the inflammatory process. Biochemical Society Transactions 35(2):281-283. |
|
|
Jian L, Yuan X, Han J, Zheng R, Peng X, Wang K (2021). Screening for illegal addition of glucocorticoids in adulterated cosmetic products using ultra-performance liquid chromatography/tandem mass spectrometry with precursor ion scanning. Rapid Communications in Mass Spectrometry 35(3):1-2. |
|
|
Johnson AR, Forster SP, White D, Terife G, Lowinger M, Teller RS, Barrett SE (2021). Drug eluting implants in pharmaceutical development and clinical practice. Expert Opinion on Drug Delivery 0(0). |
|
|
Keykhosravi S, Rietveld IB, Couto D, Tamarit JL, Barrio M, Moussa F (2019). Criterion towards Regulatory Considerations. Materials 2p. |
|
|
Kitteringham NR, Jenkins RE, Lane CS, Elliott VL, Park BK (2009). Multiple reaction monitoring for quantitative biomarker analysis in proteomics and metabolomics. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 877(13):1229-1239. |
|
|
Kumar SP, Sherpa DD, Sahu AK, Jadav T, Tekade RK, Sengupta P (2021). Innovation in bioanalytical strategies and in vitro drug-drug interaction study approaches in drug discovery. Bioanalysis 13(6):513-532. |
|
|
Leurs U, Mistarz UH, Rand KD (2016). Applications of Mass Spectrometry in Drug Development Science pp. 253-289. |
|
|
Li Z, Zhang X, Liao J, Fan X, Cheng Y (2021). An ultra-robust fingerprinting method for quality assessment of traditional Chinese medicine using multiple reaction monitoring mass spectrometry. Journal of Pharmaceutical Analysis 11(1):88-95. |
|
|
Maia TM, Staes A, Plasman K, Pauwels J, Boucher K, Argentini A, Martens L, Montoye T, Gevaert K, Impens F (2020). Simple Peptide Quanti fi cation Approach for MS-Based Proteomics Quality Control. |
|
|
Masson GR, Jenkins ML, Burke JE, Masson GR, Jenkins ML, Burke JE, Masson GR (2017). Expert Opinion on Drug Discovery An overview of hydrogen deuterium exchange mass spectrometry (HDX-MS) in drug discovery discovery. Expert Opinion on Drug Discovery 12(10):981-994. |
|
|
Mazurek S, Pichlak K, Szostak R (2021). Quantitative determination of vitamins a and e in ointments using raman spectroscopy. Processes 9(1):1-9. |
|
|
McCabe JW, Hebert MJ, Shirzadeh M, Mallis CS, Denton JK, Walker T E, Russell DH (2021). the Ims Paradox: a Perspective on Structural Ion Mobility-Mass Spectrometry. Mass Spectrometry Reviews 40(3):280-305. |
|
|
Miller RA, Spellman DS (2014). Mass spectrometry-based biomarkers in drug development. Advances in Experimental Medicine and Biology 806:341-359. |
|
|
Mitra G (2021). Emerging Role of Mass Spectrometry-Based Structural Proteomics in Elucidating Intrinsic Disorder in Proteins. Proteomics 21(3-4):1-14. |
|
|
Motoyaji T (2020). Drug Discovery?: Recent Progress and the Future Revolution of Small Molecule Drug Discovery by Affinity Selection. Mass Spectrometry Technology 68(3):191-193. |
|
|
Nordon A, McGill CA, Littlejohn D (2001). Process NMR spectrometry. Analyst 126(2):260-272. |
|
|
Papac DI, Shahrokh Z (2001). Mass Spectrometry Innovations in Drug Discovery and Development 18(2). |
|
|
Parker CE, Borchers CH (2014). Mass spectrometry based biomarker discovery, verification, and validation - Quality assurance and control of protein biomarker assays. Molecular Oncology 8(4):840-858. |
|
|
Pepi LE, Sanderson P, Stickney M, Amster IJ (2021). Developments in mass spectrometry for glycosaminoglycan analysis: A review. Molecular and Cellular Proteomics 20:100025. |
|
|
Phadke R, Mundhe A, Gosar A (2019). Drug Impurity profiling an emerging task to Pharmaceutical Industries now days - A Review. 9(March). |
|
|
Rinehart J, Barber KW (2017). The ABCs of PTMs Karl. Physiology & Behavior 176(3):139-148. |
|
|
Rufer AC (2021). Drug discovery for enzymes. Drug Discovery Today pp. 1-12. |
|
|
Schulz S, Becker M, Groseclose MR, Schadt S, Hopf C (2019). ScienceDirect Advanced MALDI mass spectrometry imaging in pharmaceutical research and drug development. Current Opinion in Biotechnology 55:51-59. |
|
|
Weitzel KM (2011). Bond?dissociation energies of cations-Pushing the limits to quantum state resolution. Mass spectrometry reviews 30(2):221-235. |
|
|
Xiao W, Oefner PJ (2001). Denaturing high-performance liquid chromatography: A review. Human Mutation 17(6):439. |
|
|
Zhang X, Li Q, Xu Z, Dou J (2020). Mass spectrometry-based metabolomics in health and medical science?: a systematic review. RSC Advances pp. 3092-3104. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
